<DOC>
	<DOCNO>NCT00567866</DOCNO>
	<brief_summary>This study test ability medicine ( Quetiapine ) use treat schizophrenia bipolar disorder reduce effect methamphetamine make difficult user stop use . This study test ability medicine use treat schizophrenia bipolar disorder reduce effect methamphetamine make difficult user stop use . The investigator think quetiapine lessen effect methamphetamine .</brief_summary>
	<brief_title>Methamphetamine-Quetiapine Interactions Humans</brief_title>
	<detailed_description>The specific goal project examine whether quetiapine alter behavioral effect methamphetamine without produce major cardiovascular change toxic effect control laboratory condition . This goal accomplish use methamphetamine challenge procedure quetiapine give orally prior intravenous ( iv ) methamphetamine administration . This allow rapid systematic evaluation therapeutic potential medication . Results drug-interaction study help determine investigation clinical efficacy dopamine-active agent . We hypothesize quetiapine reduce self-reported , performance cardiovascular effect methamphetamine .</detailed_description>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Must age 1850 . 2 . Must experience IV methamphetamine use , selfreported recent history weekly use great total administer study . Recent use confirm urine toxicology screen positive amphetamine . We recruit moderate frequent user methamphetamine . Moderate use define use twice every six week weekly . Frequent user define individual use great weekly . 3 . Must recent use confirm urine toxicology screen positive amphetamine . 4 . Must seek treatment methamphetamine abuse/dependence . 1 . Ill health ( major cardiovascular , renal , endocrine , hepatic disorder ) . 2 . Current diagnosis drug alcohol physical dependence ( nicotine caffeine ) . 3 . History major organic psychiatric disorder ( psychosis , schizophrenia , bipolar , mania ) significant psychiatric symptom time evaluation study participation , include suicidal ideation . 4 . Pregnancy , plan become pregnant fertile woman without adequate mean contraception . 5 . Present recent use overthecounter prescription psychoactive drug drug would major interaction drug test . 6 . Medical contraindication prior serious adverse effect methamphetamine stimulant ( i.e. , seizure , cardiac arrest ) medical contraindication test agent ( see risk section ) . Significant physical psychiatric illness might impair ability safely complete study might complicate study drug , include prior seizure ( age 8 ) active neurological disease clinically significant abnormality physical examination screen laboratory value . 7 . Current enrollment methamphetamine , alcohol , drug treatment program current legal problem relate methamphetamine , alcohol , drug use , include await trial supervision parole probation officer 8 . Body Mass Index &gt; 30 &lt; 18 9 . Currently try quit methamphetamine use seek treatment methamphetamine use 10 . History serious adverse event hypersensitivity methamphetamine study drug 11 . Currently take medication ( include highly active antiretroviral therapy ( HAART ) HIV ) overthecounter nonsteroidal antiinflammatory medication , topical medication , inhale asthma therapy , overthecounter nonsedating antihistamine 12 . Use within last month Vicks Nasal Inhaler medication metabolize methamphetamine ( e.g . selegiline )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>